pregnanolone has been researched along with Neurodegenerative Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Nicola, AF; Gonzalez Deniselle, MC; Guennoun, R; Labombarda, F; Liere, P; Schumacher, M | 1 |
| Eckert, A; Grimm, A; Lang, UE; Mensah-Nyagan, AG; Schmitt, K | 1 |
| Chung, BC; Weng, JH | 1 |
| Dietschy, JM; Li, H; Liu, B; Repa, JJ; Turley, SD | 1 |
2 review(s) available for pregnanolone and Neurodegenerative Diseases
| Article | Year |
|---|---|
Progesterone and allopregnanolone in the central nervous system: response to injury and implication for neuroprotection.
Topics: Animals; Brain; Brain Injuries; Brain Ischemia; Central Nervous System; Female; Humans; Male; Membrane Proteins; Neurodegenerative Diseases; Neuroprotective Agents; Pregnanolone; Progesterone; Receptors, GABA-A; Receptors, Progesterone; Spinal Cord; Spinal Cord Injuries | 2015 |
Nongenomic actions of neurosteroid pregnenolone and its metabolites.
Topics: 17-alpha-Hydroxypregnenolone; Animals; Depression; Humans; Microtubules; Neurodegenerative Diseases; Neurotransmitter Agents; Pregnanolone; Pregnenolone | 2016 |
2 other study(ies) available for pregnanolone and Neurodegenerative Diseases
| Article | Year |
|---|---|
Improvement of neuronal bioenergetics by neurosteroids: implications for age-related neurodegenerative disorders.
Topics: Adenosine Triphosphate; Aging; Androstane-3,17-diol; Animals; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Energy Metabolism; Estradiol; Estrone; Humans; Membrane Potential, Mitochondrial; Mice; Mitochondria; Neurodegenerative Diseases; Neurons; Neurotransmitter Agents; Oxygen Consumption; Pregnanolone; Progesterone; Reactive Oxygen Species; Superoxide Dismutase; Testosterone | 2014 |
Genetic variations and treatments that affect the lifespan of the NPC1 mouse.
Topics: Animals; Cyclodextrins; DNA-Binding Proteins; Gene Deletion; Genetic Variation; Intracellular Signaling Peptides and Proteins; Liver X Receptors; Longevity; Mice; Mice, Knockout; Neurodegenerative Diseases; Niemann-Pick C1 Protein; Niemann-Pick Diseases; Orphan Nuclear Receptors; Pregnanolone; Proteins; Receptors, Cytoplasmic and Nuclear; Sialyltransferases; Treatment Outcome | 2008 |